RAVERUS THERAPEUTICS

Welcome to the Brand page for “RAVERUS THERAPEUTICS”, which is offered here for Pharmaceutical preparations for the prevention of liver diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention of monogenic diseases and disorders; pharmaceutical preparations for the treatment of monogenic diseases and disorders; pharmaceutical preparations for the prevention of metabolic diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; therapeutic preparations for the prevention of liver diseases and disorders; therapeutic preparations for the treatment of liver diseases and disorders; therapeutic preparations for the prevention of kidney diseases and disorders; therapeutic preparations for the treatment of kidney diseases and disorders; therapeutic preparations for the prevention of central nervous system diseases and disorders; therapeutic preparations for the treatment of central nervous system diseases and disorders; therapeutic preparations for the prevention of monogenic diseases and disorders; therapeutic preparations for the treatment of monogenic diseases and disorders; therapeutic preparations for the prevention of metabolic diseases and disorders; therapeutic preparations for the treatment of metabolic diseases and disorders;providing health and medical information; providing a website featuring health and medical information;therapeutics;research and development of pharmaceuticals for the treatment of rare diseases; medical research;.

Its status is currently believed to be active. Its class is unavailable. “RAVERUS THERAPEUTICS” is believed to be currently owned by “RETROPHIN, INC.”